NCT04886739View on ClinicalTrials.gov

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

PHASE2CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions

Rosacea

Interventions

DRUG

CGB-400

Topical gel

DRUG

Vehicle Gel

Topical gel

Trial Locations (1)

94538

Cage Bio Investigative Site 1, Fremont

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

CAGE Bio Inc.

INDUSTRY

NCT04886739 - CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea | Biotech Hunter | Biotech Hunter